ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 5, 2007, 10.1183/09031936.00011507
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
31/3/592    most recent
09031936.00011507v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milman, N.
Right arrow Articles by Hoffmann, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milman, N.
Right arrow Articles by Hoffmann, A. L.
Eur Respir J 2008; 31:592-598
Copyright ©ERS Journals Ltd 2008

Childhood sarcoidosis: long-term follow-up

N. Milman1 and A. L. Hoffmann2

1 The Heart Centre, Division of Lung Transplantation, Rigshospitalet, University of Copenhagen, Copenhagen, and 2 Dept of Paediatrics, Næstved Hospital, Næstved, Denmark.

CORRESPONDENCE: N. Milman, Lindevangen 87B, DK-2830 Virum, Denmark, Fax: 45 35452648. E-mail: nils.mil{at}dadlnet.dk

Keywords: Children, follow-up, granulomatosis, sarcoidosis

Received: January 31, 2007
Accepted November 12, 2007

The aim of the present study was to describe clinical features and long-term survival in childhood sarcoidosis.

In total, 46 ethnic Caucasian Danish children (aged <16 yrs, 24 males) with sarcoidosis were identified in 1979–1994. In 33 (72%) children, diagnosis was verified by histology and, in the remaining 13, by clinical and radiological findings. In total, 37 subjects had a follow-up examination. Median (range) age at onset of disease was 14 (0.7–15.8) yrs and median (range) clinical follow-up was 15 (3–23) yrs after onset of disease. The median (range) age at clinical follow-up was 28 (17–30) yrs.

At follow-up: 36 (78%) children recovered completely; 30 (65%) showed complete clinical regression at a median (range) 0.7 (0.6–5.9) yrs after onset of disease; two (4%) recovered with organ damage (unilateral loss of vision, abnormal chest radiograph); five (11%) still had chronic active disease with multiorgan involvement and impaired lung function; and three (7%) were deceased, due to central nervous system sarcoidosis and acute myeloid leukaemia probably caused by cytostatics.

In Danish children, sarcoidosis had a favourable prognosis; the majority recovered <6 yrs after onset of disease. Some developed chronic active disease and impairment of pulmonary function, demanding continuous medical treatment. Prognosis was not related to the age at onset of disease. Erythema nodosum was associated with a good prognosis, and central nervous system involvement with a poor prognosis.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 637 - 649.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.